August 14, 2025

Discovery and In-Vivo Characterization of K

View Full Paper

Ask AI

Bookmark

Authors

RSRomain SiegristIdorsia (Switzerland)OBOlivier BezençonIdorsia (Switzerland)CDCaroline DeymierIdorsia (Switzerland)

Discussion

Member takes

Implication

In vitro assays discover a new class of antiseizure drugs, improving neuronal hyperexcitability in rodent models, suggesting potential treatments for epilepsy.

Key Points

Approximately 30% of epilepsy patients experience uncontrolled seizures despite available antiseizure drugs.
A new class of urea compounds was identified as having in vivo efficacy in rodent models of epilepsy.
Compound 31 demonstrated oral bioavailability and favorable tolerability in treating seizures.
The mechanism of action involves activation of KV7 potassium channels, offering a novel approach to managing neuronal excitability.

Cite This Study

Siegrist et al. (2025) studied this question.

synapsesocial.com/papers/689fc6912abb084d53ed2628 https://doi.org/10.1021/acs.jmedchem.5c00945

View Full Paper

Ask AI

Bookmark

Implication

In vitro assays discover a new class of antiseizure drugs, improving neuronal hyperexcitability in rodent models, suggesting potential treatments for epilepsy.

Discovery and In-Vivo Characterization of K

Discussion

Member takes

Implication

Key Points

Cite This Study

Discovery and In-Vivo Characterization of K

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider